Clinical Trial Update: Phase 3 Trial of a Bivalent Human Papilloma Virus (HPV) Vaccine (Cecolin®) in Young Girls [Phase 3]

View source ↗

Summary

Phase 3 results from the bivalent HPV vaccine Cecolin in young girls have been completed, with results posted in January 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Cecolin (HPV-16/18 bivalent vaccine)

Snippet

Sponsor: PATH | Conditions: Cervical Cancer | Phase 3 | Status: COMPLETED | Results posted: 2025-01-30